InvestorsHub Logo
Followers 23
Posts 3826
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Friday, 10/20/2017 8:19:02 AM

Friday, October 20, 2017 8:19:02 AM

Post# of 345890
This is it... They are doing exactly what Ronin said they wanted to do....

"Peregrine Pharmaceuticals, Inc. is a company transitioning from an R&D focused business to a pure play contract development and manufacturing organization (CDMO). Peregrine's in-house CDMO services, including cGMP manufacturing and development capabilities, are provided through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com).

The company is pursuing to license or sell its proprietary R&D assets, including its lead immunotherapy candidate, bavituximab, which is currently being evaluated in clinical trials in combination with immune stimulating therapies for the treatment of various cancers."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News